Genetic Technologies
GENE
#10406
Rank
โ‚น0.34 B
Marketcap
โ‚น70.70
Share price
0.00%
Change (1 day)
-66.66%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.07 a decrease over its 2022 EPS that were of -โ‚น2.04.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.0750.65%
2022-โ‚น2.04-99.04%
2021-โ‚น211.94-46.67%
2020-โ‚น397.40-99.38%
2019-โ‚น63,58310809.09%
2018-โ‚น582.85-41.07%
2017-โ‚น989.07-18.37%
2016-โ‚น1,212-40.24%
2015-โ‚น2,028-53.41%
2014-โ‚น4,352-10.66%
2013-โ‚น4,87171.3%
2012-โ‚น2,844-622.73%
2011โ‚น543.99-108.8%
2010-โ‚น6,182-3.92%
2009-โ‚น6,43473.47%
2008-โ‚น3,70924.96%
2007-โ‚น2,968-10.93%
2006-โ‚น3,332-48.62%
2005-โ‚น6,486-8.31%
2004-โ‚น7,073
2003N/A-100%
2002-โ‚น4,392-9.36%
2001-โ‚น4,846

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,642N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น798.49N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น468.56N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น947.28N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น27.73N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น256.05N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น400.17N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,089N/A๐Ÿ‡บ๐Ÿ‡ธ USA